Optimal Timing of Percutaneous Transhepatic Gallbladder Drainage in HighRisk Acute Cholecystitis Patients and Its Impact on Elective Laparoscopic Cholecystectomy
Executive Summary
This briefing document synthesizes the findings of a retrospective study conducted by Sakarie M H et al. (2025) regarding the impact of the timing of Percutaneous Transhepatic Gallbladder Drainage (PTGBD) on subsequent elective Laparoscopic Cholecystectomy (LC). The research focused on "high-risk" patients—primarily the elderly and those with significant comorbidities—diagnosed with acute cholecystitis.
The core finding of the study is that early PTGBD intervention (performed within ≤2 days of symptom onset) significantly improves surgical outcomes for elective LC performed at a later date. Key takeaways include:
Surgical Efficiency: Early intervention leads to significantly shorter operation times and reduced intraoperative blood loss.
Reduced Complexity: Patients receiving early PTGBD showed a lower rate of severe adhesions and a lower rate of conversion from laparoscopic to open surgery.
Pathological Progression: Delays in PTGBD are positively correlated with increased surgical difficulty and advanced pathological inflammation (e.g., necrotizing or suppurative cholecystitis).
Bridge to Surgery: While PTGBD effectively manages acute symptoms in high-risk patients who cannot tolerate immediate surgery, it should be viewed as a "bridge" to definitive treatment rather than a final solution for calculous cholecystitis.
Overview of PTGBD in Clinical Practice
Acute cholecystitis, the inflammation of the gallbladder, is typically treated with Laparoscopic Cholecystectomy (LC) as the gold standard. However, for patients classified as high surgical risk due to age, critical illness, or high Charlson Comorbidity Index (CCI) scores, immediate surgery is often contraindicated.
The Role of PTGBD
Introduced in 1982, PTGBD serves as a minimally invasive decompression method. It involves placing a drainage tube into the gallbladder under ultrasound or CT guidance, typically using the Seldinger technique. Its primary functions are:
Decompressing the gallbladder in cases of cystic duct obstruction.
Alleviating clinical symptoms and inflammatory processes.
Providing a stabilization period to reverse organ system failure before definitive surgery.
Severity Classification (Tokyo Guidelines 2018)
The study utilized the Tokyo Guidelines 2018 (TG18) to classify the severity of acute cholecystitis and identify high-risk patients:
Comparative Analysis: Early vs. Late PTGBD Intervention
The study categorized 66 patients into two groups based on the time from symptom onset to PTGBD: Early Intervention (≤2 days, n=30) and Late Intervention (>2 days, n=36).
Surgical Difficulty and Outcomes
The timing of PTGBD significantly influenced the difficulty of the elective LC performed six weeks later.
Key Finding: A Spearman correlation coefficient of 0.25 (P=0.043) confirms a positive correlation between the interval time (onset to PTGBD) and the surgical conversion rate.
Indications for PTGBD Placement
The reasons for choosing PTGBD over immediate surgery varied between the groups:
Early Group: Higher incidence of sepsis (40% vs. 16.7%, P=0.034).
Late Group: Higher incidence of persistent fever (19.4% vs. 0%, P=0.013).
General Risk Factors: High-risk factors included heart surgery within two months, lung infection, end-stage liver disease, and hemodynamic instability.
Pathological Findings and Tissue Impact
The timing of intervention directly impacts the pathological state of the gallbladder at the time of elective surgery.
Tissue Fibrosis: Delayed intervention allows for increased inflammation and subsequent fibrosis. Severe fibrosis between the gallbladder and liver tissues makes dissection during LC more challenging.
Chronic vs. Acute Stages: The "Early" group had a significantly higher proportion of cases resulting in a diagnosis of chronic cholecystitis (63.6% vs 27.3% in the late group, P=0.003).
Severe Adhesion Link: Chronic cholecystitis cases had a significantly lower severe adhesion rate (9.1%) compared to cases diagnosed with oedematous, necrotizing, or suppurative cholecystitis (66.7%).
Clinical Implementation and Catheter Management
Procedural Success
The success rate for PTGBD is reported at approximately 85.6% for typical acute cholecystitis. It leads to rapid resolution of clinical symptoms, including sepsis, in high-risk patients. The study noted no procedure-related deaths and no significant difference in catheter-related complications (dislocation, bleeding, infection) between early and late groups.
Post-Procedural Protocol
Management of the PTGBD catheter follows a structured assessment:
Interval: Elective LC is generally evaluated after six weeks.
Assessment: Repeat cholangiography assess cystic duct patency and stone presence.
Clamping Test: For non-surgical candidates, the catheter is clamped for 1–2 weeks before removal if the patient remains asymptomatic and the duct is patent.
Conclusion and Recommendations
The study concludes that the timing of PTGBD is a critical factor in the management of high-risk acute cholecystitis.
Primary Recommendation: Clinicians should decide on the treatment approach promptly upon admission. If early LC is not feasible due to high surgical risk, PTGBD should be performed as soon as possible (ideally within 48 hours of symptom onset).
Surgical Benefit: Early drainage halts the progression of inflammation, preventing the severe adhesions and fibrosis that complicate delayed laparoscopic surgery.
Limitation: While PTGBD is a vital "bridge," it may be associated with higher readmission and mortality rates in certain Grade III populations compared to those who can tolerate early LC, necessitating careful, individualized evaluation based on TG18 guidelines.
